# K150990: ECVUE Mapping System

- Pathway: 510(k) (Special)
- Applicant: Cardioinsight Technologies, Inc.
- Decided: Jul 2, 2015 after 78 days
- Product code: DQK (Computer, Diagnostic, Programmable)
- Device class: 2
- Regulation: 21 CFR 870.1425
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 7 generations back to K000248 (2000). 14 ancestors in all.
7 later devices descend from it; 1 cites it directly.
0 of 22 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K140497: Ecvue Mapping System, Cardioinsight Technologies, Inc. (2014) Summary page 4.

## Most influential descendants
- K162440: CardioInsight Cardiac Mapping System (2016), 6 descendants of its own
- K181918: CardioInsight Cardiac Mapping System (2018), 2 descendants of its own
- K211546: Vektor Computational ECG Mapping System (vMap) (2021), 1 descendant of its own
- K183195: VIVO (2019), 1 descendant of its own
- K253861: Acorys Mapping System (2026), 0 descendants of its own

## Indications for use
The CardioInsight ECVUE Mapping System is intended for acquisition, analysis, display and storage of cardiac electrophysiological data and maps for analysis by a physician.

Source page: https://510kreport.com/device/K150990
Methodology: https://510kreport.com/methodology